TDGF1 Antikörper (N-Term)
-
- Target Alle TDGF1 Antikörper anzeigen
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TDGF1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Reacts with mouse ~18 kDa (core form) and ~36 kDa (glycosylated/ post-transcriptionally modified form) TDGF1 protein
- Kreuzreaktivität (Details)
- May cross reacts with human protein. (78 % sequence homology).
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic peptide made to an N-terminal portion of the murine cripto protein sequence
- Top Product
- Discover our top product TDGF1 Primärantikörper
-
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 1-188) antibody
TDGF1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) antibodyTDGF1 Reaktivität: Human, Ratte, Maus IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 37-70), (N-Term) antibodyTDGF1 Reaktivität: Maus WB, FACS Wirt: Kaninchen Polyclonal RB51515 unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 18-48), (N-Term) antibodyTDGF1 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB3957 unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Internal Region) antibodyTDGF1 Reaktivität: Human, Ratte, Maus ELISA, WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 35-188) antibodyTDGF1 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 1-188) antibodyTDGF1 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Internal Region) antibodyVerified TDGF1 Reaktivität: Human ELISA, IHC Wirt: Ziege Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibodyTDGF1 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- WB : 1/500 to 1/2 000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
- Target
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
- Andere Bezeichnung
- Teratocarcinoma-Derived Growth Factor 1 (TDGF1 Produkte)
- Synonyme
- CR antikoerper, CRGF antikoerper, CRIPTO antikoerper, CR1 antikoerper, cripto antikoerper, cb85 antikoerper, tdgf1 antikoerper, wu:fe01d04 antikoerper, zgc:109829 antikoerper, Cripto-1 antikoerper, cr1 antikoerper, cr1a antikoerper, frl-1 antikoerper, frl1 antikoerper, xcr1 antikoerper, TDGF1 antikoerper, tdgf3 antikoerper, cripto-3 antikoerper, teratocarcinoma-derived growth factor 1 antikoerper, teratocarcinoma-derived growth factor 1, member 3 L homeolog antikoerper, teratocarcinoma-derived growth factor 1, member 1 antikoerper, TDGF1 antikoerper, Tdgf1 antikoerper, tdgf1 antikoerper, tdgf1.3.L antikoerper, tdgf1.1 antikoerper
- Pathways
- EGFR Signaling Pathway
-
